General
Preferred name
METHYLTESTOSTERONE
Synonyms
Perandren ()
L-589.372 ()
CDB-110 ()
RU-24400 ()
NSC-139965 ()
Methitest ()
Testovis ()
Android 10 ()
L-589372 ()
17-methyltestosterone ()
NSC-9701 ()
Oreton Methyl ()
Android 5 ()
Plex Hormone ()
L 589.372 ()
Oxandrolone impurity, methyltestosterone- ()
Testred ()
Metandren ()
Potensan Fte ()
Methyltestosterone ciii ()
Android 25 ()
RU 24400 ()
Virilon ()
U-2842 ()
Oreton ()
17?-Methyltestosterone ()
P&D ID
PD003096
CAS
1300-17-0
58-18-4
Tags
natural product
drug
available
Approved by
FDA
First approval
1973
Drug Status
approved
Drug indication
Androgen
Solid tumour/cancer
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
METABOLISM Hepatic.; Testosterone is metabolized to 17-keto steroids through two different pathways. The major active metabolites are estradiol and dihydrotestosterone (DHT).
DESCRIPTION Methyltestosterone is a synthetic anabolic steroid used for treating men with testosterone deficiency or similar androgen replacement therapies. (GtoPdb)
Cell lines
1
Organisms
0
Compound Sets
14
Cayman Chemical Bioactives
24080
ChEMBL Approved Drugs
CHEMBL1395
ChEMBL Drugs
CHEMBL1395
DrugBank
DB06710
DrugBank Approved Drugs
DB06710
DrugCentral
3356
DrugCentral Approved Drugs
3356
DrugMAP
DMWLFGO
DrugMAP Approved Drugs
DMWLFGO
Guide to Pharmacology
6945
LSP-MoA library (Laboratory of Systems Pharmacology)
CHEMBL1395
NCATS Inxight Approved Drugs
V9EFU16ZIF
NIH Clinical Collections (NCC)
NPC Screening Collection
External IDs
45
Properties
(calculated by RDKit )
Molecular Weight
302.22
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
0
Ring Count
4
Aromatic Ring Count
0
cLogP
4.27
TPSA
37.3
Fraction CSP3
0.85
Chiral centers
6.0
Largest ring
6.0
QED
0.73
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data